FDA Approved: CITALOPRAM — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Citalopram from Cipla USA Inc., authorizing a modification to the approved generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Citalopram (Citalopram hydrobromide)

Snippet

SUPPL AP for CITALOPRAM (CITALOPRAM)